Assessment of second-line antiretroviral regimens for HIV therapy in Africa

BACKGROUND: The efficacy and toxic effects of nucleoside reverse-transcriptase inhibitors (NRTIs) are uncertain when these agents are used with a protease inhibitor in second-line therapy for human immunodeficiency virus (HIV) infection in resource-limited settings. Removing the NRTIs or replacing t...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Paton, N, Kityo, C, Walker, A, al., E
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	Massachusetts Medical Society 2014

Assessment of second-line antiretroviral regimens for HIV therapy in Africa. -н Paton, N, Kityo, C, Hoppe, A, Reid, A, Kambugu, A, Lugemwa, A, van Oosterhout, J, Kiconco, M, Siika, A, Mwebaze, R, Abwola, M, Abongomera, G, Mweemba, A, Alima, H, Atwongyeire, D, Nyirenda, R, Boles, J, Thompson, J, Tumukunde, D, Chidziva, E, Mambule, I, Arribas, JR, Easterbrook, P, Hakim, J, Walker, A, Mugyenyi, P

Хэвлэсэн 2014

Journal article

Assessment of second-line antiretroviral regimens for HIV therapy in Africa

Ижил төстэй зүйлс